2Xideas’s Idexx Laboratories IDXX Stock Holding History

2Xideas’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-4,910	Closed	-$1.72M	–	75
2022 Q2	$1.72M	Buy	4,910 +676	+16%	+$276K	0.16%	72
2022 Q1	$2.32M	Buy	+4,234	New	+$2.23M	0.16%	72

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

2Xideas's IDXX Position: Q3 2022 in Review

2Xideas sold out of Idexx Laboratories (IDXX) in Q3 2022, closing a stake of 4,910 shares — an estimated $1.72M sold.

2Xideas first reported a position in IDXX in Q1 2022 and held it in 2 quarters. The position peaked at $2.32M in Q1 2022. 922 funds tracked by Wall St. Rank hold IDXX as of Q3 2022.

2Xideas reported no remaining Idexx Laboratories position as of Q3 2022 after selling out during the quarter.
2Xideas sold 4,910 Idexx Laboratories shares in Q3 2022, an estimated $1.72M.
2Xideas first reported a position in Idexx Laboratories in Q1 2022 and held it in 2 quarters.
2Xideas's Idexx Laboratories position peaked at $2.32M in Q1 2022.
922 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2022.

Based on 2Xideas's 13F filing for Q3 2022, filed 14 Nov 2022.